Serum visfatin level is associated with complexity of coronary artery disease in patients with stable angina pectoris.

Hakan DumanAli Gökhan Özyıldızİlkay BahçeciHandan DumanAbdulkadir UsluElif Ergül

Published in: Therapeutic advances in cardiovascular disease (2019)

Serum visfatin level was positively correlated with CAD severity in patients with high SYNTAX score. Serum visfatin level can be a useful biomarker for predicting high SYNTAX scores in patients with angina pectoris undergoing CAG.

Keyphrases

coronary artery disease
percutaneous coronary intervention
coronary artery bypass grafting
cardiovascular events
coronary artery
type diabetes
heart failure
cardiovascular disease
aortic stenosis